Novo Nordisk Total Current Liabilities 2010-2024 | NVO

Novo Nordisk total current liabilities for the quarter ending September 30, 2024 were $30.712B, a 21.91% increase year-over-year.

  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
  • Novo Nordisk total current liabilities for 2022 were $17.125B, a 8.16% increase from 2021.
  • Novo Nordisk total current liabilities for 2021 were $15.833B, a 47.07% increase from 2020.

Novo Nordisk Total Current Liabilities 2010-2024 | NVO

  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
  • Novo Nordisk total current liabilities for 2022 were $17.125B, a 8.16% increase from 2021.
  • Novo Nordisk total current liabilities for 2021 were $15.833B, a 47.07% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B